Instruments

Name Stock exchange Average volume Price Type
EMMA VILLAS S.P.A. EAV

Borsa Italiana +1 Other

6,571 2.75 EUR Stock Emma Villas S.p.A. Stock
EMMA VILLAS S.P.A. B1K

Deutsche Boerse AG

- 2.69 EUR Stock Emma Villas S.p.A.

News (487)

GSK : Q1 2024 results transcript PU
GSK : Q1 2024 results slides PU
GSK : Q1 2024 results infographic PU
Transcript : GSK plc, Q1 2024 Earnings Call, May 01, 2024
GSK raises forecast, boosted by vaccines RE
GSK expects momentum to continue after strong first quarter AN
GSK ups outlook; Next first-quarter beats forecast AN
GSK : Director/Pdmr Shareholding - Form 6-K PU
GSK CEO Emma Walmsley's total pay rises 51% to nearly 13 million pounds in 2023 RE
GSK CEO EMMA WALMSLEY TOTAL REMUNERATION IN 2023 12.7 MLN STG VS… RE
GSK : Governance and Remuneration report 2023 PU
GSK announces Dr Jeannie Lee to join the Board as Non-Executive Director | GSK AQ
Transcript : GSK plc, Q4 2023 Earnings Call, Jan 31, 2024
GSK Bets on Further Growth After Shingles and RSV Vaccines Boost Sales -- 2nd Update DJ
GSK profit up on Arexvy boost in 2023 but total payout down AN
Stocks lack direction ahead of Fed, BoE AN
Stocks called up; GSK revenue and profit up AN
Business and tech heavyweights to boost productivity through AI AQ
Transcript : GSK plc Presents at J.P. Morgan 42nd Annual Healthcare Conference 2024, Jan-09-2024 07:30 AM
UK Stocks-Factors to watch on Dec 1 RE
GSK CEO says RSV vaccine revenue to top 1 bln pounds in first year RE
GSK to begin phase 3 trials of low-carbon Ventolin inhaler in 2024 AN
GSK announces major step towards sustainability ambitions with advancement of low carbon Ventolin programme to Phase III trials | GSK AQ
GSK : announces major step towards sustainability ambitions with advancement of low carbon Ventolin programme to Phase III trials PU
Stocks prosper ahead of central bank rate calls AN
Transcript : GSK plc, Q3 2023 Earnings Call, Nov 01, 2023
FTSE 100 up, FTSE 250 down as Aston Martin tumbles AN
GSK ups guidance as boosted by Shingrix and Arexvy AN
GSK : Q3 2023 infographic PU
GSK raises annual guidance following Arexvy launch AN
GSK launches £6m programme to boost STEM career progression for young people from under-represented groups in the UK | GSK AQ
GSK : launches £6m programme to boost STEM career progression for young people from under-represented groups in the UK PU
GSK lifts growth ambitions for HIV business on long-acting drug RE
GSK announces Wendy Becker to join the Board as Non-Executive Director | GSK AQ
GSK : announces Wendy Becker to join the Board as Non-Executive Director - Form 6-K PU
GSK : announces Wendy Becker to join the Board as Non-Executive Director PU
GSK Seeks M&A CI
Transcript : GSK plc Presents at Bank of America Global Healthcare Conference, Sep-14-2023 10:05 AM
GSK : Q2 2023 Results transcript PU
Transcript : GSK plc, Q2 2023 Earnings Call, Jul 26, 2023
GSK : Q2 2023 Results infographic PU
GSK raises annual guidance on quarterly earnings growth AN
GSK : Q2 2023 infographic PU
GSK : Q2 2023 Results slides PU
GSK raises 2023 earnings guidance on strong second-quarter sales RE
1234NextSee all

Companies (3)

EMMA VILLAS S.P.A. 21 M $
Logo Emma Villas S.p.A.

Emma Villas SpA is an Italy-based Company engaged in the Residential Real Estate Rental & Development Industry. Emma Villas is a tour operator firm active in weekly tourist rentals of prestigious villas and farmhouses with private pools, to which it combi ...

BOX SHIPS INC. 3 115 $
Logo Box Ships Inc.

Box Ships Inc. is an international shipping company. The Company is engaged in the seaborne transportation of containers across the world. The Company is focused on pursuing opportunities in the container shipping industry. The Company's fleet comprises a ...

BOX SHIPS INC. 3 115 $
Logo Box Ships Inc.

Box Ships Inc. is an international shipping company. The Company is engaged in the seaborne transportation of containers across the world. The Company is focused on pursuing opportunities in the container shipping industry. The Company's fleet comprises a ...


Insiders

Emma Walmsley
Emma Walmsley

Emma N.
Walmsley
is currently the Chief Executive Officer & Executive Director at GSK Plc since 2017.
She is also the Chief Executive Officer at GlaxoSmithKline Australia Pty Ltd.
Additionally, she serves as an Independent Director at Microsoft Corp.
and as a Member at Stanford Medicine.
Previously, Ms. Walmsley held the position of Chief Executive Officer at GlaxoSmithKline Consumer Healthcare Pte Ltd.
and GlaxoSmithKline Consumer Healthcare Holdings Ltd.
She was also a Non-Executive Director at Diageo Plc in 2016.
Furthermore, she worked as the General Manager-Consumer Products at L'Oreal (China) Co., Ltd.Ms. Walmsley completed her graduate degree at the University of Oxford.



Picture John Arthur Walmsley
John Arthur Walmsley

John Arthur Walmsley formerly worked at Hardy Plc, as Chief Executive Officer in 1998, Pantheon Resources Plc, as Co-Chairman from 2013 to 2019, Orosur Mining, Inc., as Non-Executive Chairman from 2013 to 2019, The Consilience Energy Advisory Group Ltd., as Executive Chairman, Seeboard Plc, as Non-Executive Director, Bonsanco Advisory Services (UK) Ltd., as Director, Bonsanco Technologies AG, as Director, Intelligent Investors Ltd., as Director, Enterprise Oil Ltd., as MD, Head-Finance & Business Development in 1993, and Arthur Andersen (UK), as Tax Partner.








No results for this search

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW